JBIO vs ANAB

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 03, 2026

JBIO

55.4
AI Score
VS
JBIO Wins

ANAB

42.9
AI Score

Investment Advisor Scores

JBIO

55score
Recommendation
HOLD

ANAB

43score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric JBIO ANAB Winner
Forward P/E 0 21.0084 Tie
PEG Ratio 0 0 Tie
Revenue Growth 0.0% 23.5% ANAB
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 55.4/100 42.9/100 JBIO
Profit Margin 0.0% 247.0% ANAB
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

JBIO 1M: -34.0% · 3M: -33.7% ANAB 1M: -13.1% · 3M: -22.1%

Current Technical Phase

JBIO

Markdown
Sell / avoid

Price below a falling SMA50 (slope -9.1%), weak momentum, RSI 24

RSI (14): 24.2 · Price: $14.12

ANAB

Markdown
Sell / avoid

Price below a falling SMA50 (slope -5.6%), weak momentum, RSI 29

RSI (14): 28.7 · Price: $48.53

Fundamentals Snapshot

Metric JBIO ANAB
Market Cap — —
Forward P/E -5.3 9.6
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.0% 0.2%
Gross Margin — 1.1%
Operating Margin 0.0% 0.5%
EPS -1.05 -0.99
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, JBIO is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.